retatrutide phase 2 trial type 2 diabetes weight loss as a Novel Treatment for Obesity and Clinical trials of subcutaneous tirzepatide,

Pill You must take the pill daily, on an empty stomach, with 4 ounces of water or less

You prioritize lean mass preservation

Words such as "believes", "expects", "anticipates", "may", "will", "should", "seeks", "approximately", "potential", "intends", "projects", "plans", "estimates" or the negative of these words or other comparable terminology (as well as other words or expressions referencing future events, conditions or circumstances) are intended to identify forward-looking statements

Therefore, it is not recommended that individuals who are planning pregnancy or currently pregnant use GLP-1RAs

Eligibility and prescription required

A mechanistic rationale for incretin-based therapeutics in the management of obesity